Zalicus Initiates SYNERGY Trial - Zacks.com

Zalicus Initiates SYNERGY Trial Zacks.com by Jason Napodano, CFA Zalicus (ZLCS - Analyst Report) announced it has initiated a phase 2b clinical trial evaluating Synavive for the treatment of rheumatoid arthritis (RA). The trial, SYNERGY (SYNavivE for Reducing signs and sYmptoms of rheumatoid ... Zalicus Initiates SYNERGY TrialDaily Markets all 3 news articles »

Abbott signs deal with German firm to treat autoimmune diseases - Chicago Tribune

Abbott signs deal with German firm to treat autoimmune diseases Chicago Tribune ... one of the world's most popular drugs for autoimmune diseases, said today it has signed a deal that could cost nearly 0 million to gain right's to a German company's experimental drug to treat rheumatoid arthritis and other autoimmune diseases. ... Abbott signs RA pact with Germany's BiotestPharma Times all 53 news articles »

Early diagnosis can help slow arthritis - DesMoinesRegister.com

Early diagnosis can help slow arthritis DesMoinesRegister.com Rheumatoid arthritis includes pain in the joints and affects one percent of the adult population. Symptoms include morning stiffness and joint pain that goes away with activity. “If untreated or unchecked, it is ultimately a destructive disease,” Craig ... and more »

10 Things You Should Know About Lyme and Other Tick-Borne Diseases - HealthNewsDigest.com

HealthNewsDigest.com

10 Things You Should Know About Lyme and Other Tick-Borne Diseases HealthNewsDigest.com The symptoms of Lyme disease (also known as the Great Imitator) may mimic those of multiple sclerosis, lupus, chronic fatigue, fibromyalgia, mononucleosis, Alzheimers, Guillian-Barre Syndrome, ALS, rheumatoid arthritis, Parkinson's Disease, ... and more »